PSORIASIS (PSO)

This early-phase study tests an experimental drug called S-4321 in 24 adults with autoimmune diseases like rheumatoid arthritis, psoriasis, lupus, or eczema. The main goal is to check safety and how the body processes the drug. Researchers will also look at early signs of effecti…

This study looks at whether a single session of audio-based therapy can reduce anxiety in adults with psoriasis. About 120 people will listen to a 23-30 minute audio program at home and report their anxiety levels before and after. The goal is to find an easy, accessible way to h…

This study looks at whether tongue and facial images can help doctors understand psoriasis vulgaris, a common skin condition. Researchers will collect images and lab data from 450 people with and without psoriasis. The goal is to find patterns that link traditional Chinese medici…

This study will look at the health records of 350 people with psoriasis in Costa Rica to find out how common related conditions like obesity, diabetes, heart disease, and psoriatic arthritis are. Researchers will also see which treatments patients are using and how severe their p…

This study will follow 50 people in Costa Rica who are already taking IL-23 inhibitors (guselkumab or risankizumab) for psoriasis or psoriatic arthritis. Researchers will track how well the drugs improve skin and joint symptoms and quality of life, and note any side effects. The …

This study aims to find early signs of psoriatic arthritis in people who have psoriasis but not yet arthritis. About 3,458 adults across Europe will use a smartphone app and optional smartwatch to track health data. The goal is to develop digital tools that can predict arthritis …